Orthofix Medical (OFIX) Competitors

AtriCure (NASDAQ:ATRC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking.

Do analysts rate ATRC or OFIX?

AtriCure presently has a consensus target price of $49.44, indicating a potential upside of 50.85%. Orthofix Medical has a consensus target price of $23.33, indicating a potential upside of 66.56%. Given Orthofix Medical's higher possible upside, analysts plainly believe Orthofix Medical is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	3.00
Orthofix Medical	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, ATRC or OFIX?

AtriCure has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500.

Is ATRC or OFIX more profitable?

AtriCure has a net margin of -9.61% compared to Orthofix Medical's net margin of -15.18%. AtriCure's return on equity of -6.80% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-9.61%	-6.80%	-5.19%
Orthofix Medical	-15.18%	-21.25%	-13.29%

Does the media prefer ATRC or OFIX?

In the previous week, AtriCure had 5 more articles in the media than Orthofix Medical. MarketBeat recorded 10 mentions for AtriCure and 5 mentions for Orthofix Medical. AtriCure's average media sentiment score of 1.44 beat Orthofix Medical's score of 0.32 indicating that AtriCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orthofix Medical	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger earnings and valuation, ATRC or OFIX?

AtriCure has higher earnings, but lower revenue than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$465.31M	3.44	-$44.70M	-$0.95	-34.50
Orthofix Medical	$799.49M	0.68	-$151.40M	-$3.29	-4.26

Do insiders & institutionals have more ownership in ATRC or OFIX?

99.1% of AtriCure shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 3.2% of AtriCure shares are held by insiders. Comparatively, 2.6% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor ATRC or OFIX?

AtriCure received 156 more outperform votes than Orthofix Medical when rated by MarketBeat users. Likewise, 69.66% of users gave AtriCure an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote.

Company	Underperform	Outperform
AtriCure	Outperform Votes 574 69.66%	Underperform Votes 250 30.34%
Orthofix Medical	Outperform Votes 418 62.20%	Underperform Votes 254 37.80%

Summary

AtriCure beats Orthofix Medical on 14 of the 17 factors compared between the two stocks.